Search

Your search keyword '"Yves-Marie Pers"' showing total 48 results

Search Constraints

Start Over You searched for: Author "Yves-Marie Pers" Remove constraint Author: "Yves-Marie Pers" Topic 03 medical and health sciences Remove constraint Topic: 03 medical and health sciences
48 results on '"Yves-Marie Pers"'

Search Results

1. Immunomodulation with IL-17 and TNF-α in spondyloarthritis: focus on the eye and the central nervous system

2. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

3. Faible efficacité des anti-TNF dans la spondyloarthrite axiale non-radiographique en l’absence de signes objectifs : étude rétrospective bicentrique

4. Cellules souches mésenchymateuses et médecine régénératrice

5. Identification of a Novel Serum Proteomic Signature for Primary Sjögren’s Syndrome

6. Revisiting the cardiovascular risk of hydroxychloroquine in RA

7. Efficacy of tocilizumab in patients with hand osteoarthritis: double blind, randomised, placebo-controlled, multicentre trial

8. A randomized prospective open-label controlled trial comparing the performance of a connected monitoring interface versus physical routine monitoring in patients with rheumatoid arthritis

9. Successful long-term remission through tapering tocilizumab infusions: a single-center prospective study

10. Immunoglobulin Abnormalities in Gaucher Disease: an Analysis of 278 Patients Included in the French Gaucher Disease Registry

11. Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature

12. Association of TRAF1-C5 with risk of uveitis in juvenile idiopathic arthritis

13. Essential Competencies in Prescribing: A First European Cross-Sectional Study Among 895 Final-Year Medical Students

14. La thérapie cellulaire appliquée aux tissus musculo-squelettiques : état des lieux

15. Implication of IL-17 in Bone Loss and Structural Damage in Inflammatory Rheumatic Diseases

16. Economic Evaluation of Sequences of Biological Treatments for Patients With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response or Intolerance to Methotrexate in France

17. Long-term corticosteroid use and dietary advice: a qualitative analysis of the difficulties encountered by patient

18. Treatment of refractory adult onset Still’s disease with combination anakinra and baricitinib therapy

19. TGFβi is involved in the chondrogenic differentiation of mesenchymal stem cells and is dysregulated in osteoarthritis

20. Rheumatoid arthritis treated with 6-months of first-line biologic or biosimilar therapy: an updated systematic review and network meta-analysis

21. Intra-monocyte Pharmacokinetics of Imiglucerase Supports a Possible Personalized Management of Gaucher Disease Type 1

22. Médecine régénérative de la gonarthrose : mythe ou réalité ?

23. Handgrip strength measured by a dynamometer connected to a smartphone: a new applied health technology solution for the self-assessment of rheumatoid arthritis disease activity

24. Monitoring of patients with systemic lupus erythematosus during the COVID-19 outbreak

25. Taking in consideration the bystander effects of articular senescence

26. A single nucleotide polymorphism of IL6-receptor is associated with response to tocilizumab in rheumatoid arthritis patients

27. Cholangiocarcinoma occurring in a patient with type 1 Gaucher disease treated with velaglucerase alfa enzyme replacement therapy: First case report

28. Injection of Adipose-Derived Stromal Cells in the Knee of Patients with Severe Osteoarthritis has a Systemic Effect and Promotes an Anti-Inflammatory Phenotype of Circulating Immune Cells

29. Characteristics of the musculoskeletal symptoms observed among survivors of Ebola virus disease in the Postebogui cohort in Guinea

30. MicroRNA Profiling of B Cell Subsets from Systemic Lupus Erythematosus Patients Reveals Promising Novel Biomarkers

31. Tocilizumab and mesenteric arterial thrombosis: drug-drug interaction with anticoagulants metabolized by CYP 450 and/or by P-glycoprotein

32. Perspectives of ofatumumab as CD20 targeted therapy in rheumatoid arthritis and other autoimmune diseases

33. Remission-induction therapies for early rheumatoid arthritis: evidence to date and clinical implications

34. Heart Involvement in a Woman Treated with Hydroxychloroquine for Systemic Lupus Erythematosus Revealing Fabry Disease

35. Deregulation and therapeutic potential of microRNAs in arthritic diseases

36. miR-125b controls monocyte adaptation to inflammation through mitochondrial metabolism and dynamics

37. Adipose derived stem cells for regenerative therapy in osteoarticular diseases

38. Le site de référence du Partenariat européen d’innovation pour un vieillissement actif et en bonne santé MACVIA-LR (contre les maladies chroniques pour un vieillissement en bonne santé en Languedoc-Roussillon)

39. Adipose Mesenchymal Stromal Cell-Based Therapy for Severe Osteoarthritis of the Knee: A Phase I Dose-Escalation Trial

40. Impact of imiglucerase supply constraint on the therapeutic management and course of disease in French patients with Gaucher disease type 1

41. TNFRII polymorphism is associated with response to TNF blockers in rheumatoid arthritis patients seronegative for ACPA

42. Predictors of response and remission in a large cohort of rheumatoid arthritis patients treated with tocilizumab in clinical practice

43. Non–TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug

44. Longitudinal immunomonitoring following Tocilizumab in rheumatoid arthritis

45. Targeted delivery to inflammatory monocytes for efficient RNAi-mediated immuno-intervention in auto-immune arthritis

46. BIK is a novel pro-apoptotic target gene for miR-125b in human monocytes

47. p16INK4a and its regulator miR-24 link senescence and chondrocyte terminal differentiation-associated matrix remodeling in osteoarthritis

48. miR-155 Contributes to the Immunoregulatory Function of Human Mesenchymal Stem Cells

Catalog

Books, media, physical & digital resources